Senestech (NASDAQ:SNES – Get Free Report) and IM Cannabis (NASDAQ:IMCC – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, valuation, earnings, analyst recommendations, institutional ownership and profitability.
Earnings and Valuation
This table compares Senestech and IM Cannabis”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Senestech | $2.22 million | 3.94 | -$6.38 million | ($1.89) | -0.87 |
| IM Cannabis | $39.17 million | 0.04 | -$8.10 million | ($1.75) | -0.15 |
Institutional and Insider Ownership
5.2% of Senestech shares are owned by institutional investors. Comparatively, 7.7% of IM Cannabis shares are owned by institutional investors. 2.2% of Senestech shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Analyst Recommendations
This is a breakdown of current ratings and recommmendations for Senestech and IM Cannabis, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Senestech | 1 | 1 | 0 | 1 | 2.33 |
| IM Cannabis | 1 | 0 | 0 | 0 | 1.00 |
Volatility and Risk
Senestech has a beta of 0.28, indicating that its share price is 72% less volatile than the S&P 500. Comparatively, IM Cannabis has a beta of 1.99, indicating that its share price is 99% more volatile than the S&P 500.
Profitability
This table compares Senestech and IM Cannabis’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Senestech | -304.22% | -67.60% | -49.21% |
| IM Cannabis | -27.65% | -585.96% | -39.96% |
Summary
IM Cannabis beats Senestech on 7 of the 13 factors compared between the two stocks.
About Senestech
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
About IM Cannabis
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.
Receive News & Ratings for Senestech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senestech and related companies with MarketBeat.com's FREE daily email newsletter.
